Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity

ROIV Quotes by TradingView

Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.65 Million shares of ROIV, which is worth approximately $33.6 Million. The most recent transaction as insider was on Dec 24, 2025, when has been sold 75,000 shares (Common Shares) at a price of $22.53 per share, resulting in proceeds of $1,689,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M
9.94% 3M change
123.3% 12M change
Total Value Held $33.6 Million

Eric Venker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 24 2025
SELL
Open market or private sale
$1,689,750 $22.53 p/Share
75,000 Reduced 4.34%
1,654,597 Common Shares
Dec 24 2025
BUY
Exercise of conversion of derivative security
$453,714 $3.85 p/Share
117,848 Added 6.38%
1,729,597 Common Shares
Dec 23 2025
SELL
Open market or private sale
$4,490,000 $22.45 p/Share
200,000 Reduced 11.04%
1,611,749 Common Shares
Dec 23 2025
BUY
Exercise of conversion of derivative security
$1,208,287 $3.85 p/Share
313,841 Added 14.76%
1,811,749 Common Shares
Dec 09 2025
SELL
Open market or private sale
$4,170,000 $20.85 p/Share
200,000 Reduced 11.78%
1,497,908 Common Shares
Dec 09 2025
BUY
Exercise of conversion of derivative security
$770,000 $3.85 p/Share
200,000 Added 10.54%
1,697,908 Common Shares
Nov 20 2025
SELL
Payment of exercise price or tax liability
$142,923 $20.27 p/Share
7,051 Reduced 0.47%
1,497,908 Common Shares
Nov 07 2025
SELL
Open market or private sale
$4,044,000 $20.22 p/Share
200,000 Reduced 11.73%
1,504,959 Common Shares
Nov 07 2025
BUY
Exercise of conversion of derivative security
$770,000 $3.85 p/Share
200,000 Added 10.5%
1,704,959 Common Shares
Oct 17 2025
SELL
Open market or private sale
$2,020,211 $17.06 p/Share
118,418 Reduced 7.29%
1,504,959 Common Shares
Oct 17 2025
BUY
Exercise of conversion of derivative security
$1,876,925 $15.85 p/Share
118,418 Added 6.8%
1,623,377 Common Shares
Oct 16 2025
SELL
Open market or private sale
$5,426,708 $17.05 p/Share
318,282 Reduced 17.46%
1,504,959 Common Shares
Oct 16 2025
BUY
Exercise of conversion of derivative security
$5,044,769 $15.85 p/Share
318,282 Added 14.86%
1,823,241 Common Shares
Oct 15 2025
SELL
Open market or private sale
$7,020,583 $16.93 p/Share
414,683 Reduced 21.6%
1,504,959 Common Shares
Oct 15 2025
BUY
Exercise of conversion of derivative security
$6,572,725 $15.85 p/Share
414,683 Added 17.76%
1,919,642 Common Shares
Oct 13 2025
SELL
Open market or private sale
$336,813 $16.25 p/Share
20,727 Reduced 1.36%
1,504,959 Common Shares
Oct 13 2025
BUY
Exercise of conversion of derivative security
$328,522 $15.85 p/Share
20,727 Added 1.34%
1,525,686 Common Shares
Oct 09 2025
SELL
Open market or private sale
$1,710,522 $16.3 p/Share
104,940 Reduced 6.52%
1,504,959 Common Shares
Oct 09 2025
BUY
Exercise of conversion of derivative security
$1,663,299 $15.85 p/Share
104,940 Added 6.12%
1,609,899 Common Shares
Oct 08 2025
SELL
Open market or private sale
$2,245,352 $16.2 p/Share
138,602 Reduced 8.43%
1,504,959 Common Shares
Oct 08 2025
BUY
Exercise of conversion of derivative security
$1,614,713 $11.65 p/Share
138,602 Added 7.78%
1,643,561 Common Shares
Oct 07 2025
SELL
Open market or private sale
$5,735,850 $16.15 p/Share
355,161 Reduced 19.09%
1,504,959 Common Shares
Oct 07 2025
BUY
Exercise of conversion of derivative security
$3,214,207 $9.05 p/Share
355,161 Added 16.03%
1,860,120 Common Shares
Oct 06 2025
SELL
Open market or private sale
$2,800,610 $16.34 p/Share
171,396 Reduced 10.22%
1,504,959 Common Shares
Oct 06 2025
BUY
Exercise of conversion of derivative security
$1,551,133 $9.05 p/Share
171,396 Added 9.28%
1,676,355 Common Shares

Also insider at

IMVT
Immunovant, Inc. Healthcare
Chief Executive Officer
EV

Eric Venker

President & Immunovant CEO
London, X0

Track Institutional and Insider Activities on ROIV

Follow Roivant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

News

Receive news related to Roivant Sciences Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ROIV